Lupin announces sale of Japanese arm Kyowa Pharmaceutical
11 Nov 2019

Lupin Ltd on Monday announced the sale of entire 99.82% stake in its Japanese subsidiary Kyowa Pharmaceutical Industry Co Ltd for an enterprise value of 57.4 billion yen to Plutus Ltd, the Indian pharmaceutical company notified the stock exchanges.